ENTA logo

Enanta Pharmaceuticals (ENTA)

Profile

Full Name

Enanta Pharmaceuticals, Inc.

Ticker Symbol

ENTA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 21, 2013

Indexes

Not included

Website

http://www.enanta.com

Employees

131

Key Details

Price

$5.22(+5.88%)

Market cap

$111.36M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$67.64M(-14.61% YoY)

Annual EPS

-$5.48(+14.11% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.22
ENTA price is $5.22

30-Day Relative Volume

0.96
ENTA 30-day relative volume is 0.96

Price Performance

Price Today change

+5.88%
ENTA price is up +5.88% today

Price YTD change

-9.22%
ENTA price is down -9.22% since January 1st

Price 1-year change

-67.68%
ENTA price is down -67.68% year-on-year

Price 3-year change

-92.97%
ENTA price is down -92.97% over the past 3 years

Price Range

Price All-time high

$127.77
ENTA price is currently -95.91% below its historical high of $127.77

Price 3-year low

$4.09
ENTA price is currently +27.63% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$111.36M
ENTA market capitalization is $111.36 million

Market cap 3-year change

-92.73%
ENTA market capitalization is down -92.73% over the past 3 years

Market cap All-time high

$2.45B
ENTA market capitalization is currently -95.45% below its historical high of $2.45 billion

Market cap sector rank

49.92%
ENTA market capitalization is higher than 49.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.72%
ENTA shares outstanding is up +0.72% year-on-year

Shares Outstanding 3-Year Change

+3.47%
ENTA shares outstanding is up +3.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.88
ENTA beta is 0.88

200-day SMA

$9.47
ENTA price is currently -44.90% below its 200-day simple moving average

50-day SMA

$6.29
ENTA price is currently -16.96% below its 50-day simple moving average

RSI

38.48
ENTA 14-day relative strength index is 38.48

Volume

0.96
ENTA 30-day relative volume is 0.96

ATR

$0.46
ENTA average true range is $0.46

10-day Historical Volatility

82.23%
ENTA 10-day historical volatility is 82.23%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$67.64M
ENTA annual revenue is $67.64 million

Revenue Analysts estimate

$63.36M
ENTA annual revenue is currently +6.75% higher than the consensus analysts' forecast

Revenue 1-year change

-14.61%
ENTA annual revenue is down -14.61% year-on-year

Revenue Sector rank

51.4%
ENTA annual revenue is higher than 51.4% of companies in Healthcare sector

EPS

EPS

-$5.48
ENTA annual earnings per share is -$5.48

EPS Analysts estimate

-$4.42
ENTA annual earnings per share is currently +23.89% higher than the consensus analysts' forecast

EPS 1-year change

+14.11%
ENTA annual earnings per share is up +14.11% year-on-year

EPS Sector rank

18.03%
ENTA annual earnings per share is higher than 18.03% of companies in Healthcare sector

Profit

Gross profit

-
ENTA annual gross profit value is unknown

Gross margin

-
ENTA annual gross profit margin value is unknown

Operating profit

-$121.69M
ENTA annual operating income is -$121.69 million

Operating margin

-179.92%
ENTA annual operating profit margin is -179.92%

Net income

-$116.05M
ENTA annual net profit is -$116.05 million

Net margin

-171.58%
ENTA annual net profit margin is -171.58%

Expenses

Total expenses

$189.33M
ENTA annual total expenses is $189.33 million

Operating expenses

$189.33M
ENTA annual total operating expenses is $189.33 million

Cost of goods sold

-
ENTA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$57.85M
ENTA annual SGA is $57.85 million

Depreciation and amortization

$2.34M
ENTA annual depreciation & amortization is $2.34 million

Interest expense

$10.94M
ENTA annual interest expense is $10.94 million

Income tax

-$1.74M
ENTA annual income tax is -$1.74 million

EBIT & EBITDA

EBIT

-$106.85M
ENTA annual earnings before interest & taxes is -$106.85 million

EBITDA

-$104.51M
ENTA annual EBITDA is -$104.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$376.65M
ENTA annual total assets is $376.65 million

Non current assets

$76.80M
ENTA annual long term assets is $76.80 million

Current assets

$299.85M
ENTA annual total current assets is $299.85 million

Cash and cash equivalents

$37.23M
ENTA annual cash & cash equivalents is $37.23 million

Accounts receivable

$6.65M
ENTA annual accounts receivable is $6.65 million

Inventory

-
ENTA annual inventory value is unknown

Liabilities

Total liabilities

$247.84M
ENTA annual total liabilities is $247.84 million

Long term liabilities

$190.30M
ENTA annual total long term liabilities is $190.30 million

Current liabilities

$57.53M
ENTA annual total current liabilities is $57.53 million

Accounts payable

$8.00M
ENTA annual accounts payable is $8.00 million

Debt

Total debt

$55.47M
ENTA annual total debt is $55.47 million

Total debt 1-year change

+109.21%
ENTA annual total debt is up +109.21% year-on-year

Long term debt

$53.94M
ENTA annual long term debt is $53.94 million

Short term debt

$1.52M
ENTA annual short term debt is $1.52 million

Equity & Capital

Shareholders equity

$128.81M
ENTA annual stockholders equity is $128.81 million

Book value

$128.81M
ENTA annual book value is $128.81 million

Retained earnings

-$323.04M
ENTA annual retained earnings is -$323.04 million

Working capital

$242.32M
ENTA annual working capital is $242.32 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$78.76M
ENTA annual cash flow from operations is -$78.76 million

Cash from operations 1-year change

+23.64%
ENTA annual cash flow from operations is up +23.64% year-on-year

Cash from investing

$58.23M
ENTA annual cash flow from investing activities is $58.23 million

Cash from investing 1-year change

+208.69%
ENTA annual cash flow from investing activities is up +208.69% year-on-year

Cash from financing

-$27.63M
ENTA annual cash flow from financing activities is -$27.63 million

Cash from financing 1-year change

-113.94%
ENTA annual cash flow from financing activities is down -113.94% year-on-year

CAPEX

CAPEX

$17.95M
ENTA annual capital expenditures is $17.95 million

CAPEX 1-year change

+98.15%
ENTA annual capital expenditures is up +98.15% year-on-year

Free Cash Flow

Free cash flow

-$96.71M
ENTA annual free cash flow is -$96.71 million

Free cash flow 1-year change

+13.81%
ENTA annual free cash flow is up +13.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ENTA annual gross profit margin value is unknown

Operating margin

-179.92%
ENTA annual operating profit margin is -179.92%

Net margin

-171.58%
ENTA annual net profit margin is -171.58%

ROA & ROE

ROA

-27.67%
ENTA annual return on assets is -27.67%

ROE

-67.17%
ENTA annual return on equity is -67.17%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ENTA price to earnings ratio value is unknown

PE ratio Sector rank

-
ENTA price to earnings ratio is unknown

PB Ratio

PB ratio

1.00
ENTA price to book ratio is 1.00

PB ratio Sector rank

44.03%
ENTA price to book ratio is higher than 44.03% of companies in Healthcare sector

PS Ratio

PS ratio

1.67
ENTA price to sales ratio is 1.67

PS ratio Sector rank

38.85%
ENTA price to sales ratio is higher than 38.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$84.47M
ENTA enterprise value is $84.47 million

Enterprise value Sector rank

47.36%
ENTA enterprise value is higher than 47.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.89
ENTA EV/EBITDA is -0.89

EV/EBITDA Sector rank

44.96%
ENTA EV/EBITDA is higher than 44.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.21
ENTA annual current ratio is 5.21

Quick ratio

-
ENTA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ENTA annual debt to equity ratio is 0.00

Interest coverage ratio

-9.77
ENTA annual interest coverage ratio is -9.77

Risk & Stability

Piotroski F-Score

-
ENTA piotroski f-score value is unknown

Altman Z-Score

-0.92
ENTA altman z-score is -0.92

Analyst ratings

Recent major analysts updates

Feb 11, 25 JMP Securities
Market Outperform
Feb 11, 25 HC Wainwright & Co.
Buy
Dec 24, 24 HC Wainwright & Co.
Buy
Nov 26, 24 JMP Securities
Market Outperform
Nov 26, 24 Baird
Outperform
Oct 10, 24 HC Wainwright & Co.
Buy
Oct 9, 24 JMP Securities
Market Outperform
Sep 27, 24 JMP Securities
Market Outperform
Aug 6, 24 JP Morgan
Underweight
Aug 6, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

IRWD logo
Ironwood Pharmaceuticals (IRWD)
INFU logo
InfuSystem Holdings (INFU)
FATE logo
Fate Therapeutics (FATE)
AIRS logo
AirSculpt Technologies (AIRS)
TNXP logo
Tonix Pharmaceuticals Holding (TNXP)
SLS logo
SELLAS Life Sciences (SLS)
Contineum Therapeutics Class A (CTNM)
OBIO logo
Orchestra BioMed Holdings (OBIO)
LUCD logo
Lucid Diagnostics (LUCD)
  • What is the ticker symbol for Enanta Pharmaceuticals?
  • Does Enanta Pharmaceuticals pay dividends?
  • What sector is Enanta Pharmaceuticals in?
  • What industry is Enanta Pharmaceuticals in?
  • What country is Enanta Pharmaceuticals based in?
  • When did Enanta Pharmaceuticals go public?
  • Is Enanta Pharmaceuticals in the S&P 500?
  • Is Enanta Pharmaceuticals in the NASDAQ 100?
  • Is Enanta Pharmaceuticals in the Dow Jones?
  • When was Enanta Pharmaceuticals's last earnings report?
  • When does Enanta Pharmaceuticals report earnings?
  • Should I buy Enanta Pharmaceuticals stock now?

What is the ticker symbol for Enanta Pharmaceuticals?

The ticker symbol for Enanta Pharmaceuticals is NASDAQ:ENTA

Does Enanta Pharmaceuticals pay dividends?

No, Enanta Pharmaceuticals does not pay dividends

What sector is Enanta Pharmaceuticals in?

Enanta Pharmaceuticals is in the Healthcare sector

What industry is Enanta Pharmaceuticals in?

Enanta Pharmaceuticals is in the Biotechnology industry

What country is Enanta Pharmaceuticals based in?

Enanta Pharmaceuticals is headquartered in United States

When did Enanta Pharmaceuticals go public?

Enanta Pharmaceuticals's initial public offering (IPO) was on March 21, 2013

Is Enanta Pharmaceuticals in the S&P 500?

No, Enanta Pharmaceuticals is not included in the S&P 500 index

Is Enanta Pharmaceuticals in the NASDAQ 100?

No, Enanta Pharmaceuticals is not included in the NASDAQ 100 index

Is Enanta Pharmaceuticals in the Dow Jones?

No, Enanta Pharmaceuticals is not included in the Dow Jones index

When was Enanta Pharmaceuticals's last earnings report?

Enanta Pharmaceuticals's most recent earnings report was on Feb 10, 2025

When does Enanta Pharmaceuticals report earnings?

The next expected earnings date for Enanta Pharmaceuticals is May 6, 2025

Should I buy Enanta Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page